How to Read a Peptide Certificate of Analysis (COA): A Research Buyer's Guide
A Certificate of Analysis (COA) is the single most important document that accompanies a research peptide. For a laboratory purchasing lyophilized material for in-vitro or analytical work, the COA is where a supplier's claims become checkable data. It is the difference between "we say this vial contains what the label reads" and "here is the chromatogram, the mass spectrum, and the batch record that demonstrate it." This guide explains, section by section, what a well-constructed peptide COA reports, how to interpret each number, and — just as importantly — what a COA cannot tell you. Everything here is framed for research-use-only (RUO) material handled in a laboratory setting.
What a COA is and why it matters for research integrity
A Certificate of Analysis is a batch-specific analytical record. It ties a particular lot of material to a set of test results generated by defined methods. The key word is batch-specific: a COA is not a marketing sheet describing a product line in general, it describes the exact powder in the exact lot you received. Because peptide synthesis is a stepwise chemical process in which deletion sequences, truncations, incomplete deprotection, and oxidation can all occur, two lots of the "same" peptide can differ measurably. A COA is how those differences become visible.
For research integrity, this matters because your experimental conclusions inherit the identity and quality of your reagents. If a reported effect in an in-vitro assay actually traces back to a synthesis by-product, a counterion load, or a misidentified molecule, the result is not reproducible and the interpretation is wrong. A COA lets you document, in your lab notebook and your methods section, precisely what was in the vial: the sequence, the measured purity, the confirmed mass, and the lot number that lets a reader trace the material. That traceability is a cornerstone of reproducible science.
HPLC purity: reading the main-peak area percent
The headline "purity" figure on almost every peptide COA comes from reversed-phase high-performance liquid chromatography (RP-HPLC). The sample is dissolved, injected onto a column, and its components are separated as a solvent gradient carries them through at different rates. A UV detector — for peptides, typically set around 210–220 nm, where the amide backbone absorbs — records each component as it elutes, producing a chromatogram of peaks over time.
Purity is calculated as an area percent: the integrated area under the main peak divided by the summed area of all detected peaks, times 100. If the target peak integrates to 99,200 area units out of 100,000 total, the report reads 99.2%. This is why HPLC purity is often called "chromatographic purity" or "area-percent purity." A COA should show the actual chromatogram, not just a number, so you can confirm one dominant peak with only small, well-resolved impurity peaks rather than a cluster of unresolved shoulders.
Two caveats are essential. First, area percent is a relative measure at the detector's wavelength — it reflects how much UV-absorbing material each peak represents, not necessarily mole fraction, and species that co-elute under the main peak are invisible to it. Second, the number is method-dependent: gradient, column, and wavelength all affect resolution. A serious COA states the HPLC conditions so results are interpretable and, in principle, repeatable. Purity of 98–99% is common for research-grade peptides; the meaningful question is not just the percentage but whether the method could actually resolve the likely impurities.
Mass-spectrometry identity: observed versus theoretical mass
HPLC tells you how pure the main component is. It does not tell you what that component is. That is the job of mass spectrometry (MS), which measures molecular mass and lets you compare the observed mass against the theoretical mass calculated from the claimed amino-acid sequence. That comparison depends on parsing the sequence string correctly in the first place — terminal modifications, non-coded residues, and the monoisotopic-versus-average convention all shift the expected number, as set out in Peptide Nomenclature and Sequence Notation.
Most peptide COAs use electrospray ionization (ESI-MS). ESI is a soft ionization technique that sprays the dissolved peptide into charged droplets; as solvent evaporates, charge lands on the analyte and produces a series of multiply charged ions, each appearing at a different mass-to-charge (m/z) value, typically between about 500 and 2000 m/z. Because a single molecule shows up as several m/z peaks (for example [M+2H]2+, [M+3H]3+, and so on), software performs charge deconvolution: using two adjacent peaks whose charge states differ by one, it solves for both the charge and the underlying neutral mass, then averages across peaks to sharpen the estimate. As Banerjee and Mazumdar describe, this mathematical deconvolution is what turns a crowded ESI spectrum into a single molecular-weight readout. MALDI-TOF is an alternative that tends to produce singly charged ions directly.
When you read the MS section, check that the observed mass falls within a small tolerance of the theoretical value. For average masses derived from ESI on a typical peptide, agreement within roughly a dalton or so is expected; percent errors well under 0.1% are achievable on good instruments. Be aware of the difference between monoisotopic mass (calculated using the lightest isotope of each element, meaningful when isotopes are resolved) and average mass (the isotope-weighted average, appropriate for lower-resolution or larger species). A COA that reports "observed 1817.0, theoretical 1817.1" is telling you the dominant molecule carries the right total mass for the stated sequence.
Why you need BOTH: the "99% pure but wrong molecule" failure
This is the single most important concept in reading a peptide COA. HPLC purity and MS identity answer different questions, and neither substitutes for the other.
Imagine a synthesis that produced a clean, homogeneous product — one sharp HPLC peak, 99% area purity. Impressive on its own. But suppose that homogeneous product is a peptide with a single amino-acid substitution, a deletion of one residue, or an unintended modification. HPLC may not resolve that variant from the intended sequence, especially if the change is small and hydrophobicity is similar. The chromatogram looks beautiful and the purity number is high — yet the vial contains 99% of the wrong molecule. Only mass spectrometry catches this: the observed mass will not match the theoretical mass for the claimed sequence, revealing a mass shift (for example, roughly −18 Da for a lost water/serine-to-alanine-type change, or a shift matching a missing residue).
The converse also holds. MS can confirm the target mass is present while HPLC reveals that it is only, say, 80% of the material, with the rest being by-products. Purity without identity, or identity without purity, each leaves a gap large enough to invalidate an experiment. A credible COA therefore reports both an HPLC purity figure with a chromatogram and an MS result with observed-versus-theoretical mass. Treat any COA missing either half as incomplete.
Net peptide content: why the powder is not 100% peptide
A frequently misunderstood line on a COA is net peptide content (NPC), sometimes called peptide content or peptide loading. It answers a distinct question: of the total dry mass in the vial, what fraction is actually peptide? The answer is essentially never 100%, even for a 99%-pure peptide, and the reason is chemistry, not deception.
Synthetic peptides are typically isolated as salts. During purification, acidic modifiers leave a counterion bound to each basic site — most commonly trifluoroacetate (TFA, counterion mass ~114) and sometimes acetate (~59). Every basic residue (lysine, arginine, histidine) and the free N-terminal amine can carry a counterion. The theoretical net peptide content is calculated as peptide mass divided by (peptide mass + number of bound counterions × counterion mass). For a 1000-Da peptide with a free N-terminus and one lysine — two binding sites as a TFA salt — that is 1000 / (1000 + 2 × 114) = 1000/1228 ≈ 81%. The more basic residues a sequence contains, the lower the NPC of the lyophilized powder.
Counterions are not the only non-peptide mass. Lyophilized powders also hold residual water (measured by Karl Fischer titration) and adsorbed solvents (measured by gas chromatography), so theoretical NPC is only an estimate. The actual value is best determined by quantitative amino-acid analysis — acid hydrolysis followed by quantification of the released amino acids against the total sample weight — or by nitrogen/elemental analysis. The practical consequence for a laboratory: if you weigh out material to prepare a stock solution of a given concentration (mg/mL) for analytical work, the true peptide mass is NPC × weighed mass. Ignoring a net content of 80% introduces a ~20% error in every downstream concentration. Note too that NPC and HPLC purity are not the same thing — purity concerns the fraction of peptidic species that is the target, while NPC concerns the fraction of total mass that is peptide at all.
Endotoxin and LAL: what it measures and what it does not
Some COAs include an endotoxin result from the Bacterial Endotoxins Test, described in the pharmacopeias (for example USP <85>). Endotoxins are lipopolysaccharides (LPS) shed from the outer membrane of gram-negative bacteria, and they are potent pyrogens. The classic assay uses Limulus Amebocyte Lysate (LAL), an extract of horseshoe-crab blood cells that reacts specifically with LPS. Three formats exist: the qualitative gel-clot method, and the quantitative turbidimetric and chromogenic methods (the latter releasing a colored compound whose intensity scales with endotoxin). Results are reported in Endotoxin Units, typically as EU/mg for a peptide, and modern methods detect concentrations well below 0.1 EU/mL.
Read the endotoxin line for what it is: a measure of gram-negative bacterial LPS contamination, expressed as a per-milligram figure with a pass/fail threshold. Understand its limits precisely. It does not measure chemical purity or identity. It does not detect gram-positive bacteria, fungi, viruses, or non-endotoxin pyrogens, and it is not a general sterility test. Certain sample matrices can interfere and produce false readings. A low endotoxin number is a cleanliness indicator for the batch, not a statement about the peptide's structure — keep it mentally separate from the HPLC and MS results.
Batch/lot number, the third-party lab, and how to verify
A COA is only as trustworthy as its traceability. Two features carry that weight: the batch/lot number and the identity of the testing laboratory.
The lot number is what binds the certificate to your physical vial. It should appear on both the COA and the container, and it should match. Because a COA is batch-specific, a certificate for a different lot — however impressive — does not describe your material. The COA should also state the compound name, sequence, method summaries, test date, and the lab that performed the analysis.
Independent third-party testing adds credibility because the lab has no commercial stake in the result. In the research-compound space, Janoshik Analytical is a widely used independent lab that performs HPLC, mass spectrometry, and endotoxin testing and issues reports tied to a unique key. The verification mechanism matters: a PDF can be forged — anyone can typeset a document with fabricated numbers — but a matching entry in the lab's own database cannot be manufactured by a third party. Reputable labs publish a verification page (for example, Janoshik's report-verification portal) where you enter the report's unique key or ID and retrieve the original test data — purity, mass result, and test date — straight from the lab. Always verify at the lab's own domain rather than trusting a supplier-hosted image, and confirm that the verified lot matches your vial. If a COA cannot be independently verified, treat its numbers as unconfirmed claims.
What a COA cannot tell you
Even a complete, verified COA has boundaries, and knowing them keeps you honest about your reagents:
- It is a snapshot of one batch at test time. It says nothing about degradation after shipping or during storage. Stability depends on your handling — lyophilized material generally stored cold and dry, reconstituted solutions kept per the supplier's stated conditions. Purity measured at manufacture is not purity in your freezer months later.
- Standard HPLC and MS do not fully confirm sequence order or stereochemistry. MS confirms total mass; it does not, by itself, prove the residues are in the stated order or that no D-amino-acid or isobaric substitution occurred. Amino-acid analysis gives composition but, as a hydrolysis method, provides no sequence information. Establishing sequence unambiguously requires tandem MS/MS or sequencing, which routine COAs may not include.
- Co-eluting and UV-silent impurities can be missed. Anything hidden under the main HPLC peak or poorly absorbing at the detection wavelength will not show up in the area percent.
- It is not a safety, efficacy, or fitness-for-any-use document. A COA reports analytical measurements on RUO material. It does not authorize or imply any application beyond laboratory research, and it makes no claim about biological outcomes.
- A number without a method is not evidence. "99% pure" with no chromatogram, no stated conditions, no mass data, and no verifiable lot is a marketing figure, not an analytical result.
Read together, the sections of a COA form a chain: identity (MS) establishes what the molecule is, purity (HPLC) establishes how much of it is the target, net peptide content establishes how much of the powder is peptide, endotoxin (where reported) flags a specific class of contamination, and the lot number plus third-party verification make all of it traceable and checkable. A gap in any link weakens the whole. The disciplined habit — match the lot, read both HPLC and MS, sanity-check net content before weighing, and verify at the lab's own portal — turns a COA from a piece of paper into genuine documentation of what you are working with.
FAQ
Is 99% HPLC purity enough on its own? No. Area-percent purity tells you the main component dominates the chromatogram, but not that the main component is the correct molecule. Without a matching observed-versus-theoretical mass from MS, a 99%-pure sample could be 99% of the wrong peptide. Read purity and identity together.
Why is net peptide content less than 100% even at high purity? Because "purity" describes the fraction of peptidic material that is the target, while "net peptide content" describes the fraction of total dry mass that is peptide. Bound counterions (often TFA, ~114 Da each), residual water, and adsorbed solvents add non-peptide mass, so an 80–90% net content is normal — and it directly affects how you calculate stock concentrations.
What is the difference between monoisotopic and average mass on a COA? Monoisotopic mass uses the lightest isotope of each element and is used when the instrument resolves individual isotope peaks. Average mass is the isotope-weighted average, appropriate at lower resolution or for larger peptides. Make sure the observed value is compared against the same kind of theoretical mass.
How do I verify a third-party COA is genuine? Use the testing lab's own verification portal and enter the report's unique key or ID (for example, at Janoshik's verify page). Confirm that the purity, mass, and lot number returned by the lab match the document and your vial. A PDF alone can be forged; a matching database entry at the lab's domain cannot.
Does an endotoxin (LAL) pass mean the peptide is high quality? No. LAL measures gram-negative bacterial lipopolysaccharide only. It says nothing about chemical identity, purity, or other contaminants, and it is not a sterility test. Treat it as a separate, narrow cleanliness metric.
References
- Banerjee S, Mazumdar S. "Electrospray Ionization Mass Spectrometry: A Technique to Access the Information beyond the Molecular Weight of the Analyte." International Journal of Analytical Chemistry (PMC). https://pmc.ncbi.nlm.nih.gov/articles/PMC3348530/
- Bachem. "Quality Control of Amino Acids & Peptides: A Guide." https://www.bachem.com/knowledge-center/quality-control-of-amino-acids-peptides-a-guide/
- AmbioPharm. "How is Theoretical Net Peptide Content Calculated?" https://www.ambiopharm.com/faq/how-is-theoretical-net-peptide-content-calculated/
- "Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides." PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC12389442/
- Microbe Investigations. "Limulus Amebocyte Lysate (LAL) Test in USP <85>." https://microbe-investigations.com/blog/limulus-amebocyte-lysate-lal-test-in-usp-85-ensuring-safety-in-endotoxin-detection/
- Wikipedia. "Limulus amebocyte lysate." https://en.wikipedia.org/wiki/Limulus_amebocyte_lysate
- Thermo Fisher Scientific. "Endotoxins 101: Guide to Bacterial Endotoxin / LAL Testing." https://www.thermofisher.com/blog/life-in-the-lab/endotoxins-101/
- Wehofsky M, Hoffmann R. "Automated deconvolution and deisotoping of electrospray mass spectra." Journal of Mass Spectrometry (2002). https://pubmed.ncbi.nlm.nih.gov/11857767/
- ScienceDirect Topics. "Monoisotopic Mass — an overview." https://www.sciencedirect.com/topics/medicine-and-dentistry/monoisotopic-mass
- Janoshik Analytical — report verification portal. https://janoshik.com/verify